Nagreeka Cap.

Which are the latest news on Nagreeka Cap.?

Why is Nagreeka Capital & Infrastructure Ltd falling/rising?

As of 03-Aug, Nagreeka Capital & Infrastructure Ltd's stock price is at 23.40, reflecting a recent increase but underperforming its sector. Despite a short-term rise, the stock shows mixed performance indicators and a significant decline in investor participation, with a year-to-date decline of 20.92%.

As of 03-Aug, Nagreeka Capital & Infrastructure Ltd's stock price is rising, currently at 23.40, with a change of 0.21 (0.91%) increase. This rise can be attributed to a consecutive gain over the last two days, during which the stock has recorded a total return of 1.39%. However, it is important to note that despite this recent uptick, the stock has underperformed its sector today by 0.32%. <BR><BR>In terms of moving averages, the stock price is higher than the 5-day moving average but remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed performance in the short to medium term. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 60.43% compared to the 5-day average, which may suggest a lack of strong buying interest despite the recent price increase. <BR><BR>Overall, while the stock is experiencing a short-term rise, its longer-term performance remains concerning, with a year-to-date decline of 20.92% compared to a 7.72% decline in the benchmark Sensex.

Should I buy, sell or hold Nagreeka Capital & Infrastructure Ltd?

How big is Nagreeka Cap.?

As of 10th June, Nagreeka Capital & Infrastructure Ltd has a market capitalization of 38.00 Cr, classifying it as a Micro Cap company, with recent Net Sales of 46.80 Cr and a Net Profit of 7.42 Cr.

As of 10th June, Nagreeka Capital & Infrastructure Ltd has a market capitalization of 38.00 Cr, which categorizes it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 46.80 Cr and a Net Profit of 7.42 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 21.13 Cr and Total Assets of 105.38 Cr.

Who are in the management team of Nagreeka Cap.?

The management team of Nagreeka Capital includes Chairman Sushil Patwari, Managing Director Sunil Patwari, and Non-Executive Independent Directors Mohan Kishen Ogra, Bibhuti Charan Talukdar, and Surabhi Sanganeria, along with Company Secretary Vivek Jaiswal. They oversee the company's operations and strategic direction.

The management team of Nagreeka Capital includes the following individuals:<BR><BR>1. **Sushil Patwari** - Chairman<BR>2. **Sunil Patwari** - Managing Director<BR>3. **Mohan Kishen Ogra** - Non Executive Independent Director<BR>4. **Bibhuti Charan Talukdar** - Non Executive Independent Director<BR>5. **Surabhi Sanganeria** - Non Executive Independent Director<BR>6. **Vivek Jaiswal** - Company Secretary<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Who are the peers of the Nagreeka Cap.?

Nagreeka Cap.'s peers include Ajcon Global, Kiduja India, Glance Finance, Sugal & Damani, JMJ Fintech, Biogen Pharma, MPIL Corporation, Swati Projects, Shyamkamal Inv, and Amrapali Capital. Notably, Nagreeka Cap. has average management risk and a 1-year return of 2.64%, significantly lower than Amrapali Capital's 97.42% but higher than Biogen Pharma's -64.95%.

Peers: The peers of Nagreeka Cap. are Ajcon Global, Kiduja India, Glance Finance, Sugal & Damani, JMJ Fintech, Biogen Pharma, MPIL Corporation, Swati Projects, Shyamkamal Inv, and Amrapali Capital.<BR><BR>Quality Snapshot: Excellent management risk is observed at Ajcon Global, Glance Finance, Sugal & Damani, JMJ Fintech, and Swati Projects, while Average management risk is found at Nagreeka Cap. and Shyamkamal Inv. Below Average management risk is noted for Kiduja India, Biogen Pharma, and JMJ Fintech, while the peers that do not qualify are Kiduja India and MPIL Corporation. Growth ratings show Excellent growth at Sugal & Damani, JMJ Fintech, and Amrapali Capital, Good growth at Nagreeka Cap. and Shyamkamal Inv., Average growth at Glance Finance, and Below Average growth at Ajcon Global and Biogen Pharma. The peers with Capital Structure rated as Excellent include Ajcon Global, Glance Finance, Sugal & Damani, JMJ Fintech, Swati Projects, and Shyamkamal Inv., while Nagreeka Cap. has a Below Average rating, and Kiduja India and MPIL Corporation do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Amrapali Capital at 97.42%, while Biogen Pharma has the lowest at -64.95%. Nagreeka Cap.'s 1-year return is 2.64%, which is significantly higher than Biogen Pharma's but much lower than Amrapali Capital's. Additionally, the peers with negative six-month returns include Ajcon Global, JMJ Fintech, Biogen Pharma, and Kiduja India.

What does Nagreeka Cap. do?

Nagreeka Capital & Infrastructure Ltd is a manufacturer and exporter in the NBFC sector, specializing in plastic-coated aluminium and steel products. As of March 2026, it reported net sales of 21 Cr and a net loss of 2 Cr, with a market cap of INR 38 Cr.

Overview:<BR>Nagreeka Capital & Infrastructure Ltd is a leading manufacturer and exporter in the Non Banking Financial Company (NBFC) sector, focusing on plastic-coated aluminium and steel tapes, laminates, yarns, textiles, and containers.<BR><BR>History:<BR>Incorporated in 1953, Nagreeka Capital & Infrastructure Ltd was formerly known as Nagreeka Software Technologies Ltd. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 21 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: -2 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 38 Cr (Micro Cap) <BR><BR>Key Metrics:<BR>P/E: 5.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 3.32 <BR>Return on Equity: 26.00% <BR>Price to Book: 1.28 <BR><BR>Contact Details:<BR>Address: 18 R N Mukherjee Road, 3rd Floor Kolkata West Bengal : 700001 <BR>Tel: 91-33-22108828/4943 <BR>Email: rathin@nagreeka.com/sushil@nagreeka <BR>Website: http://www.nagreeka.com

Are Nagreeka Capital & Infrastructure Ltd latest results good or bad?

Nagreeka Capital & Infrastructure Ltd's latest results are concerning, showing a net loss of ₹2.34 crores in Q4 FY26, a drastic decline from the previous quarter's profit, alongside a sharp drop in operating margin and high debt levels. Overall, these factors indicate significant challenges and a high-risk situation for investors.

The latest results for Nagreeka Capital & Infrastructure Ltd are concerning. In Q4 FY26, the company reported a net loss of ₹2.34 crores, a significant decline compared to the previous quarter's profit of ₹3.29 crores. This represents a drastic QoQ change of -171.13%. Additionally, the operating margin fell sharply to -6.87% from a healthy 43.91% in the prior quarter, indicating severe operational challenges.<BR><BR>While net sales did show a positive QoQ growth of 49.93%, they were still down 15.11% compared to the same quarter last year. The overall financial performance reflects a troubling volatility in revenue and profitability, marking a critical inflection point for the company after a period of improving results.<BR><BR>Moreover, the company is facing high leverage with a debt-to-equity ratio of 4.51, which adds to the financial strain. The combination of operational losses, extreme revenue volatility, and high debt levels suggests a high-risk situation for investors. Overall, the results can be characterized as bad, highlighting significant challenges ahead for Nagreeka Capital.

When is the next results date for Nagreeka Capital & Infrastructure Ltd?

The next results date for Nagreeka Capital & Infrastructure Ltd is 28 May 2026.

The next results date for Nagreeka Capital & Infrastructure Ltd is scheduled for 28 May 2026.

How has been the historical performance of Nagreeka Cap.?

Nagreeka Capital's historical performance shows significant fluctuations, with net sales increasing from INR 4.75 crore in March 2021 to INR 55.05 crore in March 2025, and a recovery in profitability, achieving a profit after tax of INR 18.56 crore in March 2025, up from a loss of INR 64.73 crore in March 2020. However, total liabilities rose to INR 105.38 crore in March 2025, indicating ongoing financial challenges despite operational improvements.

Answer:<BR>The historical performance of Nagreeka Capital shows significant fluctuations over the years, particularly in revenue and profitability.<BR><BR>Breakdown:<BR>Nagreeka Capital's net sales have seen a notable increase from INR 4.75 crore in March 2021 to INR 55.05 crore in March 2025, although it peaked at INR 153.57 crore in March 2019. The total operating income followed a similar trend, rising to INR 57.13 crore in March 2025 from INR 10.90 crore in March 2021, despite a high of INR 159.30 crore in March 2019. Operating profit (PBDIT) has also improved, reaching INR 25.16 crore in March 2025, compared to a loss of INR 75.80 crore in March 2020. The profit before tax was INR 25.12 crore in March 2025, with profit after tax at INR 18.56 crore, indicating a recovery from previous losses, including a loss of INR 64.73 crore in March 2020. The earnings per share (EPS) rose to INR 14.71 in March 2025 from a negative INR 51.29 in March 2020. On the balance sheet, total liabilities increased to INR 105.38 crore in March 2025 from INR 35.11 crore in March 2020, while total assets also rose to INR 105.38 crore in March 2025. Cash flow from operating activities was INR 3.00 crore in March 2025, a decline from INR 28.00 crore in March 2024, reflecting challenges in cash management despite overall operational improvements.

Is Nagreeka Cap. overvalued or undervalued?

As of September 5, 2025, Nagreeka Capital is considered undervalued with a PE ratio of 1.79 and an EV to EBITDA of 5.33, significantly lower than peers like Bajaj Finance, indicating strong growth potential despite recent underperformance against the Sensex.

As of 5 September 2025, the valuation grade for Nagreeka Capital has moved from very expensive to attractive, indicating a significant shift in its perceived value. The company is currently assessed as undervalued, particularly when considering its key ratios, such as a PE ratio of 1.79, an EV to EBITDA of 5.33, and a PEG ratio of 0.21. These figures suggest that the stock is trading at a considerable discount compared to its earnings growth potential.<BR><BR>In comparison to its peers, Nagreeka Capital stands out with a much lower PE ratio than Bajaj Finance, which is at 33.5, and a more favorable PEG ratio compared to Life Insurance at 0.7. This peer analysis reinforces the notion that Nagreeka Capital is undervalued within the Non-Banking Financial Company (NBFC) sector. While the stock has underperformed against the Sensex in the year-to-date period, its strong long-term returns of 355.42% over five years highlight its potential for recovery and growth.

Who are the top shareholders of the Nagreeka Cap.?

The top shareholders of Nagreeka Capital include Dadra Eximp Private Limited with 16.69%, individual investors with 25.69%, and Lakecity Ventures Pvt Ltd as the highest public shareholder at 6.46%. There are no pledged promoter holdings.

The top shareholders of Nagreeka Capital include the promoters, with Dadra Eximp Private Limited holding the largest stake at 16.69%. Individual investors collectively hold 25.69% of the shares. Additionally, Lakecity Ventures Pvt Ltd is the highest public shareholder, with a stake of 6.46%. There are also seven mutual fund schemes that hold a small percentage (0.03%), and one foreign institutional investor (FII) with a negligible holding (0.0%). Notably, there are no pledged promoter holdings.

What is the technical trend for Nagreeka Cap.?

As of June 5, 2025, Nagreeka Cap's technical trend is neutral, showing mixed signals with a mildly bullish weekly MACD and bearish daily indicators, indicating short-term weakness despite some bullish momentum in the longer term.

As of 5 June 2025, the technical trend for Nagreeka Cap has changed from mildly bullish to sideways. The weekly MACD remains mildly bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The Bollinger Bands show a bearish stance on the weekly chart but mildly bullish on the monthly. Daily moving averages are mildly bearish, suggesting short-term weakness. The KST is mildly bullish weekly and bullish monthly, which supports some positive momentum. However, the Dow Theory indicates a mildly bullish weekly trend but a mildly bearish monthly trend. Overall, the current technical stance is neutral, with strength lacking in the daily indicators while some bullishness persists in the weekly and monthly perspectives.

Has Nagreeka Cap. declared dividend?

No Dividend History Available